TITLE

Insulin Aspart (rDNA Origin) Injection

PUB. DATE
June 2020
SOURCE
AHFS Consumer Medication Information;Jun2020, p1
SOURCE TYPE
Database
DOC. TYPE
Article
ABSTRACT
Insulin aspart is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) who need insulin to control their diabetes. In patients with type 1 diabetes, insulin aspart is usually used with another type of insulin, unless it is used in an external insulin pump. In patients with type 2 diabetes, insulin aspart also may be used with another type of insulin or with oral medication(s) for diabetes. Insulin aspart is a short-acting, manmade version of human insulin. Insulin aspart works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is used for energy. It also stops the liver from producing more sugar.
ACCESSION #
78170117

 

Related Articles

  • Insulin Detemir (rDNA Origin) Injection.  // AHFS Consumer Medication Information;Jun2020, p1 

    Insulin detemir is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore,...

  • IBD Stock Of The Day: Dexcom Nears Breakout On Medical Device Heyday. GATLIN, ALLISON // Investors Business Daily;6/20/2019, pN.PAG 

    The article offers information on the Dexcom as stock of the day on June 20, 2019. Topics discussed include views of William Blair analyst Margaret Kaczor on rising interest in continuous glucose monitors (CGMs); stock performance of the firm; and teaming up to provide better systems of CGMs and...

  • Insulin Glulisine (rDNA origin) Injection.  // AHFS Consumer Medication Information;Jun2020, p1 

    Insulin glulisine is used to treat type 1 diabetes (condition in which the body does not make insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the blood sugar is too high because the body does not...

  • Insulin Requirements in Relation to Insulin Pump Indications in Type 1 Diabetes. GHIMPEŢEANU, Gabriela; IANCU, Silvia Ş.; ROMAN, Gabriela; ALIONESCU, Anca M. // Notulae Scientia Biologicae;2015, Vol. 7 Issue 3, p259 

    The purpose of the current research was to assess changes in daily insulin requirements in type 1 diabetic patients transitioning from multiple daily injections (MDI) of insulin to continuous subcutaneous insulin infusion (CSII) using an external insulin pump, according to clinical indications...

  • The world as it is. Jendle, Johan; Adolfsson, Peter; Örnhagen, Hans // Diving & Hyperbaric Medicine: Journal of the South Pacific Under;Dec2012, Vol. 42 Issue 4, p231 

    The article presents the current Swedish recommendations for recreational divers with Type 1 diabetes mellitus. It discusses the importance of conducting systemic measurement of glucose levels using home glucometers to prevent hypoglycemia during diving. Emphasis is also given on the timing of...

  • Putting Continuous Glucose Monitoring to Work for People With Type 1 Diabetes. Hood, Korey K.; DiMeglio, Linda A.; Riddle, Matthew C. // Diabetes Care;Jan2020, Vol. 43 Issue 1, p19 

    The article focuses on monitoring glucose levels for people with type 1 Diabetes. Topic include obtain real-time and summary displays patterns of individuals with diabetes; and effects of Continuous Glucose Monitoring (CGM) device versus routine Self-Monitoring of Blood Glucose (SMBG) and of...

  • Prevention of Exercise-Associated Dysglycemia: A Case Study–Based Approach. Zaharieva, Dessi P.; Riddell, Michael C. // Diabetes Spectrum;Winter2015, Vol. 28 Issue 1, p55 

    The article discusses some common examples of exercise-associated dysglycemia and possible methods to improve glycemic control. Topics possible strategies exist for managing blood glucose levels during and after exercise for individuals with type 1 diabetes, multiple factors that can affect...

  • An Uncommon Cause of Hypoglycemia: Insulin Autoimmune Syndrome. Savas-Erdeve, Senay; Yılmaz Agladioglu, Sebahat; Onder, Asan; Peltek Kendirci, Havva Nur; Bas, Veysel Nijat; Sagsak, Elif; Cetinkaya, Semra; Aycan, Zehra // Hormone Research in Paediatrics;Oct2014, Vol. 82 Issue 4, p278 

    Background: Insulin autoimmune syndrome (IAS) is a condition characterized by hypoglycemia associated with the presence of autoantibodies to insulin in patients who have not been injected with insulin. Case Report: A female patient (aged 16 years and 3 months) presented with the complaint of...

  • A 10-s Sprint Performed After Moderate-Intensity Exercise Neither Increases nor Decreases the Glucose Requirement to Prevent Late-Onset Hypoglycemia in Individuals With Type 1 Diabetes. DAVEY, RAYMOND J.; BUSSAU, VANESSA A.; PARAMALINGAM, NIRUBASINI; FERREIRA, LUIS D.; EE MUN LIM; DAVIS, ELIZABETH A.; JONES, TIMOTHY W.; FOURNIER, PAUL A. // Diabetes Care;Dec2013, Vol. 36 Issue 12, p4163 

    OBJECTIVE--To determine whether performing a 10-s sprint after moderate-intensity exercise increases the amount of carbohydrate required to maintain euglycemia and prevent late-onset postexercise hypoglycemia relative to moderate-intensity exercise alone. RESEARCH DESIGN AND METHODS--Seven...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics